Snakebite envenoming in Africa remains widely neglected and demands multidisciplinary attention.

Snakebite envenoming can cause morbidity, permanent disability or death but treatment and prevention thereof remains highly inadequate in Africa. Overcoming structural and financial barriers that impede existing initiatives to improve medical management and mitigate human-snake conflict is urgently needed.

Snake species assemblages across habitat types in four departments of the Republic of Congo, with emphasis on medically-relevant venomous species.

Snakebite is a neglected public health crisis in sub-Saharan Africa. There is a particular lack of data (on snakes and snakebite) from the central African region. This study was conducted in the departments of Likouala, Sangha, Cuvette-Ouest and Kouilou, in the Republic of Congo.

Prevalence and therapeutic management of snakebite cases in the health facilities of the Bouenza department from 2009 to 2021, Republic of Congo.

Introduction: few studies exist of snake bites in the Republic of Congo. This study reports epidemiological and management data on snake bites in the Bouenza department of the Republic of Congo.

Methods: this is a retrospective and descriptive study based on questionnaire and analysis of files of snakebite victims over a period of 13 years (2009-2021).

IKAROS is required for the measured response of NOTCH target genes upon external NOTCH signaling.

The tumor suppressor IKAROS binds and represses multiple NOTCH target genes. For their induction upon NOTCH signaling, IKAROS is removed and replaced by NOTCH Intracellular Domain (NICD)-associated proteins. However, IKAROS remains associated to other NOTCH activated genes upon signaling and induction.

Characterization of mesoangioblast cell fate and improved promyogenic potential of a satellite cell-like subpopulation upon transplantation in dystrophic murine muscles.

Duchenne muscular dystrophy (DMD) is a lethal muscle-wasting disease caused by the lack of dystrophin in muscle fibers that is currently without curative treatment. Mesoangioblasts (MABs) are multipotent progenitor cells that can differentiate to a myogenic lineage and that can be used to express Dystrophin upon transplantation into muscles, in autologous gene therapy approaches. However, their fate in the muscle environment remains poorly characterized.